Cargando…

Controversies in management of the bladder cuff at nephroureterectomy

Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and roboti...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Avery E., Srivastava, Abhishek, Maffucci, Fenizia, Kutikov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475677/
https://www.ncbi.nlm.nih.gov/pubmed/32944551
http://dx.doi.org/10.21037/tau.2020.01.17
_version_ 1783579559864565760
author Braun, Avery E.
Srivastava, Abhishek
Maffucci, Fenizia
Kutikov, Alexander
author_facet Braun, Avery E.
Srivastava, Abhishek
Maffucci, Fenizia
Kutikov, Alexander
author_sort Braun, Avery E.
collection PubMed
description Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and robotic techniques has transformed this operation, yet no level I evidence exists at present that demonstrates the superiority of one strategy over another. While new approaches to nephroureterectomy in the last decade have shifted the management paradigm to decrease the morbidity of surgery, controversy continues to surround the approach to the distal ureter and bladder cuff. Debate continues within the urologic community over which surgical approach is best when managing UTUC and how various approaches impact clinical outcomes such as intravesical recurrence, recurrence-free survival (RFS) and disease-specific mortality (DSM). When focusing on the existing treatment algorithm, key metrics of quality include (I) removal of the entire specimen en bloc, (II) minimizing the risk of tumor and urine spillage, (III) R0 resection, and (IV) water-tight closure allowing for early use of prophylactic intravesical chemotherapy. In the absence of robust evidence demonstrating a single superior approach, the urologic surgeon should base decisions on technical comfort and each patient’s particular clinical circumstance.
format Online
Article
Text
id pubmed-7475677
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74756772020-09-16 Controversies in management of the bladder cuff at nephroureterectomy Braun, Avery E. Srivastava, Abhishek Maffucci, Fenizia Kutikov, Alexander Transl Androl Urol Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and robotic techniques has transformed this operation, yet no level I evidence exists at present that demonstrates the superiority of one strategy over another. While new approaches to nephroureterectomy in the last decade have shifted the management paradigm to decrease the morbidity of surgery, controversy continues to surround the approach to the distal ureter and bladder cuff. Debate continues within the urologic community over which surgical approach is best when managing UTUC and how various approaches impact clinical outcomes such as intravesical recurrence, recurrence-free survival (RFS) and disease-specific mortality (DSM). When focusing on the existing treatment algorithm, key metrics of quality include (I) removal of the entire specimen en bloc, (II) minimizing the risk of tumor and urine spillage, (III) R0 resection, and (IV) water-tight closure allowing for early use of prophylactic intravesical chemotherapy. In the absence of robust evidence demonstrating a single superior approach, the urologic surgeon should base decisions on technical comfort and each patient’s particular clinical circumstance. AME Publishing Company 2020-08 /pmc/articles/PMC7475677/ /pubmed/32944551 http://dx.doi.org/10.21037/tau.2020.01.17 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions
Braun, Avery E.
Srivastava, Abhishek
Maffucci, Fenizia
Kutikov, Alexander
Controversies in management of the bladder cuff at nephroureterectomy
title Controversies in management of the bladder cuff at nephroureterectomy
title_full Controversies in management of the bladder cuff at nephroureterectomy
title_fullStr Controversies in management of the bladder cuff at nephroureterectomy
title_full_unstemmed Controversies in management of the bladder cuff at nephroureterectomy
title_short Controversies in management of the bladder cuff at nephroureterectomy
title_sort controversies in management of the bladder cuff at nephroureterectomy
topic Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475677/
https://www.ncbi.nlm.nih.gov/pubmed/32944551
http://dx.doi.org/10.21037/tau.2020.01.17
work_keys_str_mv AT braunaverye controversiesinmanagementofthebladdercuffatnephroureterectomy
AT srivastavaabhishek controversiesinmanagementofthebladdercuffatnephroureterectomy
AT maffuccifenizia controversiesinmanagementofthebladdercuffatnephroureterectomy
AT kutikovalexander controversiesinmanagementofthebladdercuffatnephroureterectomy